Literature DB >> 2294809

Reducing the cost of surgical prophylaxis.

K S Scher1, J M Bernstein, G L Arenstein, C Sorensen.   

Abstract

A four-part program was implemented in order to control the rising cost of prophylactic antibiotics: limiting the number of cephalosporins on formulary; prohibiting the use of third- and most second-generation cephalosporins for prophylaxis; using a special order form to designate use as empiric, therapeutic, or prophylactic; and mandatory discontinuance of prophylactic antibiotics after 24 hours. The total cost for administration of prophylactic antibiotics was reduced from an average of $37.35 per case for the six months preceding the start of these restrictive policies to an average of $21.99 per case during the next twelve months. Class I and class II wound-infection rates were 2.0 per cent and 4.9 per cent, respectively, prior to the adoption of the new antibiotic practices. Comparable infection rates were 1.8 per cent and 2.1 per cent, respectively, after this program was initiated. The rising cost of antibiotic prophylaxis can be reduced without adversely affecting wound-infection rates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294809

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

2.  Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact?

Authors:  William Scotton; Richard Cobb; Leo Pang; Iain Nixon; Anil Joshi; Jeanne-Pierre Jeannon; Richard Oakley; Gary French; Carolyn Hemsley; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

3.  Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine.

Authors:  I C Gyssens; W L Blok; P J van den Broek; Y A Hekster; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.